- Founded
- 2022
- Employees
- 30
- Total Funding
- $71M
Founded by Sabah Oney in 2022.
About Vilya
Vilya is a computational biotechnology company creating a novel class of medicines to precisely target disease biology. Their platform is built on ground-breaking research in advanced computational approaches and taps into uncharted chemical space to design new molecular structures not found in nature. Their molecules open the door to a brand-new class of medicine with enhanced drug-like properties. They are harnessing the power of their platform to go after previously impossible targets in an array of indications.
Leadership at Vilya
The team at the top of the org chart.
Patrick Salveson
Co-founder & Chief Technology Officer
3 reports
Ivan Anishchenko
Senior Director of Deep Learning
2 reports
Nao Hiranuma
Director of Machine Learning Research
Open Jobs at Vilya (1)
Similar companies hiring
Top employers in Medical